Title 42--Public Health
CHAPTER I--PUBLIC HEALTH SERVICE, DEPARTMENT OF HEALTH AND HUMAN SERVICES PART 82--METHODS FOR CONDUCTING DOSE RECONSTRUCTION UNDER THE ENERGY EMPLOYEES OCCUPATIONAL ILLNESS COMPENSATION PROGRAM ACT OF 2000
|
|
|
82.0 |
Background information on this part. |
|
|
82.1 |
What is the purpose of this part? |
|
|
82.2 |
What are the basics of dose reconstruction? |
|
|
82.3 |
What Are the Requirements for Dose Reconstruction Under EEOICPA? |
|
|
82.4 |
How Will DOL Use the Results of the NIOSH Dose Reconstructions? |
|
|
82.5 |
Definition of terms used in this part. |
|
|
82.10 |
Overview of the dose reconstruction process. |
|
|
82.11 |
For which claims under EEOICPA will NIOSH conduct a dose reconstruction? |
|
|
82.12 |
Will it be possible to conduct dose reconstructions for all claims? |
|
|
82.13 |
What sources of information may be used for dose reconstructions? |
|
|
82.14 |
What types of information could be used in dose reconstructions? |
|
|
82.15 |
How will NIOSH evaluate the completeness and adequacy of individual monitoring data? |
|
|
82.16 |
How will NIOSH add to monitoring data to remedy limitations of individual monitoring and missed dose? |
|
|
82.17 |
What types of information could be used to supplement or substitute for individual monitoring data? |
|
|
82.18 |
How will NIOSH calculate internal dose to the primary cancer site(s)? |
|
|
82.19 |
How will NIOSH address uncertainty about dose levels? |
|
|
82.25 |
When will NIOSH report dose reconstruction results, and to whom? |
|
|
82.26 |
How will NIOSH report dose reconstruction results? |
|
|
82.27 |
How can claimants obtain reviews of their NIOSH dose reconstruction results by NIOSH? |
|
|
82.28 |
Who can review NIOSH dose reconstruction files on individual claimants? |
|
|
82.30 |
How will NIOSH inform the public of any plans to change scientific elements underlying the dose reconstruction process to maintain methods reasonably current with scientific progress? |
|
|
82.31 |
How can the public recommend changes to scientific elements underlying the dose reconstruction process? |
|
|
82.32 |
How will NIOSH make changes in scientific elements underlying the dose reconstruction process, based on scientific progress? |
|
|
82.33 |
How will NIOSH inform the public of changes to the scientific elements underlying the dose reconstruction process? |